ROY WINSTON - 04 Nov 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: Chief Medical Officer
Signature: /s/ Kristen Williams, Attorney-in-Fact
Issuer symbol: PCRX
Transactions as of: 04 Nov 2021
Net transactions value: +$481,500
Form type: 4
Filing time: 08 Nov 2021, 15:22:04 UTC
Previous filing: 05 Aug 2021
Next filing: 08 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Options Exercise	$481,500	+10,000	+27%	$48.15	46,456	04 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-40%	$0.000000	15,000	04 Nov 2021	Common Stock	10,000	$48.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years.